EQAs realizados
2023 BRCA testing for ovarian and prostate cancer - somatic
2023 BRCA testing for ovarian, breast, prostate and pancreatic cancer – germline
2023 Carrier screening (pilot)
2023 Lung cancer - EGFR only
2023 Microsatellite instability testing (MSI)
2024 BRCA testing for ovarian and prostate cancer - somatic
2024 cfDNA extraction from plasma (pilot)
2024 Circulating free (cf) DNA testing in lung cancer
2024 Hereditary Breast and Ovarian Cancer (HBOC) disorders
2024 Mitochondrial disease
2024 NGS for germline CNVs (pilot)
2024 NGS for germline SNVs and indels
2024 NGS for somatic SNVs and indels - tumour testing only
AZ Multitumor NGS Panel Ring Trial Phase 2
Programa de Control de Calidad (Quality Assurance - QA) en la detección de mutaciones del gen IGHV, organizado por ERIC
